SCHEMBL5589149

SCHEMBL5589149

Cc1c(C)c(C2CCCCC2)c(C(=O)O)c(O)c1O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LDHA P00338 2/20 0.39
LDHB P07195 2/20 0.39
ACMSD Q8TDX5 2/20 0.35
DHODH Q02127 1/20 0.34
LIPE Q05469 3/20 0.33
HSD17B10 Q99714 1/20 0.33
CXCR5 P32302 1/20 0.33
ABCC1 P33527 1/20 0.33
KMO O15229 2/20 0.33
TAS1R3 Q7RTX0 3/20 0.32
TAS1R1 Q7RTX1 2/20 0.32
TAS1R2 Q8TE23 2/20 0.32
KDM4E B2RXH2 1/20 0.32
GLA P06280 1/20 0.32
HTT P42858 1/20 0.32
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HIF1A Q16665 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1134719 0.93 LDHA (0.35) LDHALDHBACMSDDHODHLIPE
SCHEMBL10792747 0.91 LDHA (0.36) LDHALDHBACMSDDHODHLIPE
SCHEMBL5587330 0.84 LDHA (0.36) LDHALDHBACMSDDHODHLIPE
SCHEMBL17323560 0.82 DHODH (0.36) ACMSDDHODHLIPEHSD17B10ABCC1
SCHEMBL5589864 0.81 LDHA (0.46) LDHALDHBACMSDDHODH
SCHEMBL5590693 0.79 LDHA (0.39) LDHALDHB
SCHEMBL5590562 0.77 CNR2 (0.33) LIPE
SCHEMBL5589664 0.76 BCL2L1 (0.43) LDHALDHBACMSDDHODHKMO
SCHEMBL5586964 0.76 LDHA (0.34) LDHALDHBACMSDHSD17B10KMO
SCHEMBL14989167 0.75 KMO (0.41) ACMSDLIPEHSD17B10KMOKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 LDHA 320/4885LDHB 486/4885ACMSD 237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.